Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status

INTRODUCTION: We evaluated for two novel automated biomarker assays how cerebrospinal fluid (CSF) amyloid beta (Aβ)(1– 42)‐ratios improved the concordance with amyloid positron emission tomography (PET) positivity compared to Aβ(1– 42) alone. METHODS: We selected 288 individuals from the Amsterdam D...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Alzheimers Dement (Amst)
Auteurs principaux: Willemse, Eline A. J., Tijms, Betty M., van Berckel, Bart N. M., Le Bastard, Nathalie, van der Flier, Wiesje M., Scheltens, Philip, Teunissen, Charlotte E.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2021
Sujets:
Cerebrospinal Fluid Biomarkers
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088096/
https://ncbi.nlm.nih.gov/pubmed/33969174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12182
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires